Send us a text

USCAP 2025 Daily Update – Day 3 Recap with Dr. Aleksandra Zuraw

In this episode of the Digital Pathology Podcast, I bring you Day 3 insights live from USCAP 2025—from moderating the MUSE panel on slide-free imaging to exploring regulatory strategies, tech innovations, and collaborations across the digital pathology community.

Get an inside look at how direct-to-digital pathology is transforming workflows, how companies like Techcyte are streamlining AI applications, and why regulatory strategy is as crucial as your scanning tech.

🔬 Key Topics Covered:

• [00:00:00] Behind the scenes: MUSE panel highlights and audience turnout
• [00:02:00] Slide-free imaging and concordance studies with Dr. Levenson and Dr. Rao
• [00:03:00] Regulatory insights from Esther Abels on digital pathology FDA strategy
• [00:05:00] Poster struggles, TikTok pathology posters, and missed moments
• [00:07:00] Techcyte’s new Fusion platform and use across cellular imaging departments
• [00:08:00] On-the-floor interviews with thought leaders and innovators
• [00:10:00] Where does glassless imaging fit into your workflow?
• [00:12:00] Collaboration opportunities and global connections at the MUSE booth
• [00:13:00] Final thoughts on community, education, and digital pathology’s future

🩺 Why This Episode Matters:
Day 3 was packed with inspiration, breakthroughs, and powerful conversations. Whether you’re navigating regulatory approval, researching AI integration, or figuring out how slide-free imaging fits into your diagnostic flow, this update offers real-world insight from experts shaping the future of pathology.

🎧 Listen now for highlights, reflections, and what’s next at USCAP 2025!

Support the show

Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!